57 related articles for article (PubMed ID: 35104421)
1. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer.
Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
[TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies.
Mogal MR; Jame JA; Sohel M; Mozibullah M; Mahmod MR; Junayed A; Kar N; Arbia L; Al Mamun A; Sikder MA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2059. PubMed ID: 38639039
[TBL] [Abstract][Full Text] [Related]
3. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.
Wang H; Guo H; Sun J; Wang Y
Sci Rep; 2023 Aug; 13(1):13564. PubMed ID: 37604837
[TBL] [Abstract][Full Text] [Related]
4. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
Xu Q; Song A; Xie Q
Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
[TBL] [Abstract][Full Text] [Related]
5. Identification of LIPH as an unfavorable biomarkers correlated with immune suppression or evasion in pancreatic cancer based on RNA-seq.
Zhuang H; Chen X; Wang Y; Huang S; Chen B; Zhang C; Hou B
Cancer Immunol Immunother; 2022 Mar; 71(3):601-612. PubMed ID: 34279685
[TBL] [Abstract][Full Text] [Related]
6. S100P as a potential biomarker for immunosuppressive microenvironment in pancreatic cancer: a bioinformatics analysis and in vitro study.
Hao W; Zhang Y; Dou J; Cui P; Zhu J
BMC Cancer; 2023 Oct; 23(1):997. PubMed ID: 37853345
[TBL] [Abstract][Full Text] [Related]
7. Identification of the Shared Gene Signatures and Biological Mechanism in Type 2 Diabetes and Pancreatic Cancer.
Hu Y; Zeng N; Ge Y; Wang D; Qin X; Zhang W; Jiang F; Liu Y
Front Endocrinol (Lausanne); 2022; 13():847760. PubMed ID: 35432196
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive prognostic and immune analysis of a glycosylation related risk model in pancreatic cancer.
Liu X; Shi J; Tian L; Xiao B; Zhang K; Zhu Y; Zhang Y; Jiang K; Zhu Y; Yuan H
BMC Cancer; 2023 Dec; 23(1):1229. PubMed ID: 38097951
[TBL] [Abstract][Full Text] [Related]
9. Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic cancer.
Zhang B; Chen X; Wang Z; Guo F; Zhang X; Huang B; Ma S; Xia S; Shang D
Aging (Albany NY); 2023 Oct; 15(19):10549-10579. PubMed ID: 37815881
[TBL] [Abstract][Full Text] [Related]
10. Upregulated expression of
He Y; Du Z; Peng H; Reddy AV; Cao P
J Gastrointest Oncol; 2024 Feb; 15(1):435-457. PubMed ID: 38482253
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic cancer and is associated with B-cell Infiltration in pancreatic cancer.
Dong C; Ma H; Mi N; Fu W; Yi J; Gao L; Wang H; Ren Y; Lin Y; Han F; Chen Z; Zhou W
Front Oncol; 2024; 14():1283164. PubMed ID: 38634049
[TBL] [Abstract][Full Text] [Related]
12. Integrated transcriptomic analysis reveals hub genes involved in diagnosis and prognosis of pancreatic cancer.
Zhou YY; Chen LP; Zhang Y; Hu SK; Dong ZJ; Wu M; Chen QX; Zhuang ZZ; Du XJ
Mol Med; 2019 Nov; 25(1):47. PubMed ID: 31706267
[TBL] [Abstract][Full Text] [Related]
13. Calpain 8 as a potential biomarker regulates the progression of pancreatic cancer via EMT and AKT/ERK pathway.
Song N; Cui K; Zeng L; Fan Y; Wang Z; Shi P; Su W; Wang H
J Proteomics; 2024 Apr; 301():105182. PubMed ID: 38697284
[TBL] [Abstract][Full Text] [Related]
14. Integrated multi-omics identified the novel intratumor microbiome-derived subtypes and signature to predict the outcome, tumor microenvironment heterogeneity, and immunotherapy response for pancreatic cancer patients.
Zhang B; Liu J; Li H; Huang B; Zhang B; Song B; Bao C; Liu Y; Wang Z
Front Pharmacol; 2023; 14():1244752. PubMed ID: 37745080
[No Abstract] [Full Text] [Related]
15. The Molecular Characteristics and Therapeutic Implications of O-Glycan Synthesis in Pancreatic Cancer by Integrating Transcriptome and Single-Cell Data.
Huang B; Zhang B; Liu J; Wang T; Zhang Y; Zhang B; Yuan Q; Xia S; Shang D
Curr Med Chem; 2024 Apr; ():. PubMed ID: 38659264
[TBL] [Abstract][Full Text] [Related]
16. Identification of Biomarkers Related to the Efficacy of Radiotherapy in Pancreatic Cancer.
Caxali GH; Brugnerotto L; Aal MCE; Castro CFB; Delella FK
Cancer Genomics Proteomics; 2023; 20(5):487-499. PubMed ID: 37643780
[TBL] [Abstract][Full Text] [Related]
17. A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation.
Wu C; Huang ZH; Meng ZQ; Fan XT; Lu S; Tan YY; You LM; Huang JQ; Stalin A; Ye PZ; Wu ZS; Zhang JY; Liu XK; Zhou W; Zhang XM; Wu JR
Chin Med; 2021 Nov; 16(1):121. PubMed ID: 34809653
[TBL] [Abstract][Full Text] [Related]
18. Implications of prognosis-associated genes in pancreatic tumor metastasis: lessons from global studies in bioinformatics.
Kisling SG; Natarajan G; Pothuraju R; Shah A; Batra SK; Kaur S
Cancer Metastasis Rev; 2021 Sep; 40(3):721-738. PubMed ID: 34591244
[TBL] [Abstract][Full Text] [Related]
19. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
[TBL] [Abstract][Full Text] [Related]
20. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target.
Ren LK; Lu RS; Fei XB; Chen SJ; Liu P; Zhu CH; Wang X; Pan YZ
J Cancer Res Clin Oncol; 2024 Mar; 150(3):127. PubMed ID: 38483604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
